Invesco’s Avalo Therapeutics AVTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q2 | – | Sell |
-7
| Closed | -$14K | – | 4013 |
|
|
2022
Q1 | $14K | Hold |
7
| – | – | ﹤0.01% | 3959 |
|
|
2021
Q4 | $33K | Hold |
7
| – | – | ﹤0.01% | 3970 |
|
|
2021
Q3 | $41K | Buy |
7
+2
| +40% | +$11.7K | ﹤0.01% | 3972 |
|
|
2021
Q2 | $45K | Sell |
5
-4
| -44% | -$36K | ﹤0.01% | 3924 |
|
|
2021
Q1 | $76K | Hold |
9
| – | – | ﹤0.01% | 3773 |
|
|
2020
Q4 | $71K | Sell |
9
-5
| -36% | -$39.4K | ﹤0.01% | 3653 |
|
|
2020
Q3 | $90K | Sell |
14
-11
| -44% | -$70.7K | ﹤0.01% | 3541 |
|
|
2020
Q2 | $188K | Buy |
25
+4
| +19% | +$30.1K | ﹤0.01% | 3454 |
|
|
2020
Q1 | $149K | Buy |
21
+3
| +17% | +$21.3K | ﹤0.01% | 3443 |
|
|
2019
Q4 | $280K | Sell |
18
-1
| -5% | -$15.6K | ﹤0.01% | 3396 |
|
|
2019
Q3 | $177K | Hold |
19
| – | – | ﹤0.01% | 3520 |
|
|
2019
Q2 | $300K | Sell |
19
-13
| -41% | -$205K | ﹤0.01% | 3460 |
|
|
2019
Q1 | $540K | Sell |
32
-12
| -27% | -$203K | ﹤0.01% | 3262 |
|
|
2018
Q4 | $412K | Sell |
44
-6
| -12% | -$56.2K | ﹤0.01% | 3325 |
|
|
2018
Q3 | $668K | Buy |
50
+24
| +92% | +$321K | ﹤0.01% | 3282 |
|
|
2018
Q2 | $327K | Buy |
+26
| New | +$327K | ﹤0.01% | 3545 |
|